Delhi High Court grants temporary relief to Abbott, Glenmark in drug ban case
Govt banned 344 drug combinations over weekend, including Abbott's codeine-based cough syrup
 "An Abbott company logo is pictured at the reception of its office in Mumbai")
An Abbott company logo is pictured at the reception of its office in Mumbai
The Delhi High Court on Tuesday granted interim injunction to US drugmaker Abbott's India unit, and domestic companies Glenmark Pharmaceuticals and Macleods Pharmaceuticals, on the prohibition on sale of several combination drugs.
India banned 344 drug combinations over the weekend, including Abbott's codeine-based cough syrup, after a government panel of experts found they had "no therapeutic justification."
The judge in the court granted an interim stay to the pharmaceutical companies and said regulators should take "no coercive steps" against them. The case will now be heard on March 21.
The Indian unit of US drugmaker Pfizer had on Monday won a similar reprieve on a ban on its popular cough syrup Corex.
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Mar 15 2016 | 5:29 PM IST